Arylsulfonylcarbamoyl-1,3-dicarbonylalicyclic and arylsulfonylcarbamoyl-1,3-dicarbony-lacyclic compounds
CA 1051924 A · Owner: Bristol-Myers Squibb Company · Inventors: Grunwald, Frederick A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
ARYLSULFONYLCARBAMOYL-1,3-DICARBONYLALICYCLIC AND ARYLSULFONYLCARBAMOYL-1,3-DICARBONYL- ACYCLIC COMPOUNDS, Abstract of the Disclosure A new class of arylsulfonylcarbamoyl-1,3-cyclohexanediones and arylsulfonylcarbamoyl-1,3-dicarbonylacyclic compounds are disclosed. These substances have hypoglycemic or hyperglycemic properties and are of value in controlling abnormal blood sugar levels. The arylsulfonylcarbamoyl derivatives of 1,3-dicarbonylalicyclic and acyclic compounds are prepared by reacting an arylsulfonylisocyanate with a 1,3-dicarbonylalicyclic or acyclic reactant. Typical embodiments are 2-(N-p-chlorobenzenesulfonylcarbamoyl)-5,5-dimethylcyclohexane- 1,3-dione and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 3, 1979. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 3, 1996.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.